| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | Exactech Inc | 31,636 | 574,000 | 0.51% | SH | |
| 52 | IRONWOOD PHARMA | 600,000 | 563,000 | 0.50% | PRN | |
| 53 | ENDOLOGIX INC | 500,000 | 545,000 | 0.49% | PRN | |
| 54 | TARGACEPT INC | 530,821 | 531,000 | 0.47% | PRN | |
| 55 | CYNAPSUS THERAPEUTICS INC | 33,995 | 526,000 | 0.47% | SH | |
| 56 | VTV THERAPEUTICS INC | 73,000 | 497,000 | 0.44% | ||
| 57 | FOAMIX PHARMACEUTICALS LTD | 60,770 | 493,000 | 0.44% | ||
| 58 | COGENTIX MED INC | 351,781 | 454,000 | 0.40% | ||
| 59 | TANDEM DIABETES CARE INC COM | 36,551 | 432,000 | 0.39% | ||
| 60 | CYTOKINETICS INC | 40,000 | 418,000 | 0.37% | ||
| 61 | BLUEBIRD BIO INC COM | 6,000 | 385,000 | 0.34% | SH | |
| 62 | NEMUS BIOSCIENCE INC | 625,000 | 341,000 | 0.30% | ||
| 63 | TENAX THERAPEUTICS INC | 79,509 | 261,000 | 0.23% | ||
| 64 | CATALYST | 70,903 | 222,000 | 0.20% | ||
| 65 | CARDICA INC | 1,402,762 | 216,000 | 0.19% | SH | |
| 66 | CHECK CAP LTD | 109,133 | 206,000 | 0.18% | ||
| 67 | VENAXIS INC | 594,800 | 181,000 | 0.16% | SH | |
| 68 | GENVEC INC | 95,800 | 176,000 | 0.16% | SH | |
| 69 | TREVENA INC | 14,800 | 155,000 | 0.14% | SH | |
| 70 | Sierra Oncology, Inc. | 10,000 | 150,000 | 0.13% | ||
| 71 | AKARI THERAPEUTICS PLC | 8,341 | 121,000 | 0.11% | ||
| 72 | Nivalis Therapeutics Inc | 15,000 | 116,000 | 0.10% | ||
| 73 | GALMED PHARMACEUTICALS LTD | 11,988 | 91,000 | 0.08% | SH | |
| 74 | ENTEROMEDICS INC | 500,000 | 65,000 | 0.06% | ||
| 75 | ANTARES PHARMA INC | 45,000 | 54,000 | 0.05% | ||
| 76 | CEL SCI CORP | 127,482 | 47,000 | 0.04% | ||
| 77 | CHECK CAP LTD | 53,763 | 38,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000022, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
